Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 28, 2023; 29(44): 5882-5893
Published online Nov 28, 2023. doi: 10.3748/wjg.v29.i44.5882
Published online Nov 28, 2023. doi: 10.3748/wjg.v29.i44.5882
Table 1 Baseline characteristics of all patients with peptic ulcer disease, n (%)
Total (n = 26785) | |
Age ≥ 65 yr | 10392 (38.8) |
Men | 15544 (58.0) |
RUT or serology | 19601 (73.2) |
Gastric ulcer | 18527 (69.2) |
Duodenal ulcer | 8377 (31.3) |
Diagnosis | |
Hypertensive disorder | 4773 (17.8) |
Diabetes mellitus | 2239 (8.4) |
Hyperlipidemia | 2038 (7.6) |
Chronic kidney disease | 1282 (4.8) |
Ischemic heart disease | 2221 (8.3) |
Cerebrovascular disease | 812 (3.0) |
Chronic liver disease | 1436 (5.4) |
Osteoarthritis | 425 (1.6) |
Chronic obstructive lung disease | 515 (1.9) |
Medication | |
Aspirin | 4068 (15.2) |
Other antiplatelet agent1 | 3065 (11.4) |
Clopidogrel | 2386 (8.9) |
Cilostazole | 691 (2.6) |
NSAID | 5342 (19.9) |
Warfarin | 579 (2.2) |
DOAC | 297 (1.1) |
Steroid | 3404 (12.7) |
Antidepressant | 6308 (23.6) |
Bisphosphonate | 488 (1.8) |
Immunosuppressant | 578 (2.2) |
- Citation: Choi YJ, Kim TJ, Bang CS, Lee YK, Lee MW, Nam SY, Shin WG, Seo SI. Changing trends and characteristics of peptic ulcer disease: A multicenter study from 2010 to 2019 in Korea. World J Gastroenterol 2023; 29(44): 5882-5893
- URL: https://www.wjgnet.com/1007-9327/full/v29/i44/5882.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i44.5882